Atara Biotherapeutics Inc (NAS:ATRA)
$ 10.28 -1.35 (-11.61%) Market Cap: 58.33 Mil Enterprise Value: 83.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Q3 2021 Atara Biotherapeutics Inc Earnings Call Transcript

Nov 04, 2021 / 12:30PM GMT
Release Date Price: $497.25 (+6.08%)
Operator

Good day, ladies and gentlemen, and welcome to Atara Biotherapeutics Quarter 3 2021 Financial Results Conference Call. (Operator Instructions) At this time, it is my pleasure to turn the floor over to your host, Eric Hyllengren, VP, Investor Relations and Finance. Sir, the floor is yours.

Eric Hyllengren
Atara Biotherapeutics, Inc. - VP of IR & Finance

Thank you, operator. Good morning, everyone, and welcome to Atara's Third Quarter 2021 Results Conference Call. Earlier today, we issued a press release announcing our third quarter financial results and operational progress. This press release and an updated corporate slide deck are available in the Investors & Media section at atarabio.com.

On today's call, members from the Atara executive team will provide an update on our financial results and operational progress and also review our upcoming key milestones and objectives. Joining me on today's call are Dr. Pascal Touchon, President and Chief Executive Officer; Dr. Jakob Dupont, Executive Vice President and Global Head of Research and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot